Critical Innovations welcomes members of the Defense Advanced Research Projects Agency (DARPA)

On April 9, 2025, Critical Innovations hosted representatives from the Defense Advanced Research Projects Agency (DARPA) at the company’s facilities. The visit provided a platform to highlight the company’s ongoing development of the Revite™ Automated Trauma Resuscitation System, a simplified, miniaturized, and automated extracorporeal life support (ECLS)-based trauma resuscitation system. Revite™ is designed to optimize catheter flow while minimizing cannula size, vascular access requirements, and thrombotic risk. “The need for an improved ECLS-based system for managing polytrauma patients in combat settings is of growing importance, as anticipated future conflict scenarios have no guarantee of the ‘Golden Hour,’” said Dr. Ross Donaldson, President & CEO of Critical Innovations. “Revite™ can effectively extend the golden hour by providing vital support during prolonged care.”

Revite™ is being developed under DARPA’s GOLDen hour extended EVACuation (GOLDEVAC) program, which aims to expand the abilities of automated resuscitation technologies to enable medics to manage complex polytrauma patients from the point of injury through the entire evacuation process. Critical Innovations is one of three performers in the GOLDEVAC program. The visit, led by Lt. Col. Adam Willis, MD, PhD, Program Manager in DARPA’s Biological Technologies Office (BTO), included technical demonstrations and milestone reviews of Critical Innovations’ progress within the broader GOLDEVAC initiative.

The visit underscored the collaborative spirit driving GOLDEVAC and highlighted Critical Innovations’ commitment to advancing cutting-edge technologies and solutions to trauma care. The Revite™ project aligns well with Critical Innovations' mission of task-shifting life-saving interventions to earlier echelons of care.